Clinical subgroups of the Alzheimer syndrome

Acta Neurologica Scandinavica

Volumn 94, Issue SUPPL.165, 1996, Pages 51-57

  Wallin, Anders ^a   Blennow, K ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Alzheimer's disease; Classification; Dementia; Familial; Sporadic; Subgroup; Syndromes

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DEMENTIA; DISEASE CLASSIFICATION; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; PATHOPHYSIOLOGY; REVIEW;

ALZHEIMER DISEASE; HUMANS;

EID: 0029689322     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1996.tb05872.x     Document Type: Article

References (39)

1. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984: 34: 939-44.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed, rev. (DSM-III-R). Washington, DC: American Psychiatric Association, 1987.
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (DSM-IV). Washington, DC: American Psychiatric Association, 1994.
4. Mullan M., Crawford F. Genetic and molecular advances in Alzheimer's disease. TINS 1993: 16: 398-403.
5. Sherrington R., Rogaev EI, Liang Y. et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995: 375: 754-60.
6. Blennow K., Wallin A., Gottfries CG. Presence of parieto-temporal symptomatology distinguishes early- and late-onset Alzheimer's disease. Int J Geriatr Psychiatry 1991: 6: 147-54.
7. Blennow K., Wallin A. Clinical heterogeneity of "probable Alzheimer's disease. J Geriatr Psychiatry Neurol 1992: 5: 106-13.
8. Svennerholm L., Gottfries CG. Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II). J Neurochem 1994: 62: 1039-47.
9. Blennow K., Davidsson P., Wallin A. et al. Gangliosides in cerebropsinal fluid in subgroups of Alzheimer's disease. Arch Neurol 1991: 48: 1032-5.
10. de Leon MJ, George AE, Stylopoulos LA, Smith G., Miller DC. Early marker for Alzheimer's disease: the atrophic hippocampus (letter). Lancet 1989: 2: 672-3.
11. Blennow K., Wallin A., Uhlemann C., Gottfries CG. White-matter lesions on CT in Alzheimer patients: relation to clinical symptomatology and vascular factors. Acta Neurol Scand 1991: 83: 187-93.
12. Scheltens P., Leys D., Barkhof F. et al. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992: 55: 967-72.
13. Scheltens P., Barkhof F., Valk J. et al. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. Brain 1992: 115: 735-48.
14. Golomb J., de Leon MJ, Kluger A., George AE, Tarshish C., Ferris SH. Hippocampal atrophy in normal aging: an association with recent memory impairment. Arch Neurol 1993: 50: 967-73.
15. Scheltens P., Barkhof F., Leys D. et al. A semiquantitative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 1993: 114: 7-12.
16. Wallin A., Blennow K., Scheltens P. Research criteria for the clinical diagnosis of pure Alzheimer's disease. Drugs of Today 1994: 30: 265-73.
17. Blennow K., Wallin A., Gottfries CG. Confusional symptomatology distinguishes early- and late-onset Alzheimer's disease. Aging (Milan) 1990: 2: 395-401.
18. Nyth AL, Gottfries CG, Blennow K., Brane G., Wallin A. Heterogeneity of the course of Alzheimer's disease: a differentiation of subgroups. Dementia 1991: 2: 18-24.
19. Brun A., Gustafson L., Risberg J. Frontal lobe degeneration of non-Alzheimer type. Arch Gerontol Geriatr 1987: 6: 193-233.
20. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry 1994: 57: 416-8.
21. Wallin A., Blennow K., Gottfries CG. Subcortical symptoms predominate in vascular dementia. Int J Geriatr Psychiatry 1991: 6: 137-45.
22. Wallin A., Blennow K., Fredman P., Gottfries CG, Karlsson I., Svennerholm L. Blood brain barrier function in vascular dementia. Acta Neurol Scand 1990: 81: 318-22.
23. Wallin A., Gottfries CG, Karlsson I., Svennerholm L. Decreased myelin lipids in Alzheimer's disease and vascular dementia. Acta Neurol Scand 1989: 80: 319-23.
24. Fredman P., Wallin A., Blennow K., Davidsson P., Gottfries CG, Svennerholm L. Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia. Acta Neurol Scand 1992: 85: 103-6.
25. Brun A., Fredriksson K., Gustafson L. Pure subcortical arteriosclerotic encephalopathy (Binswanger's disease): a clinicopathologic study. Part 2: pathologic features. Cerebrovasc Dis 1992: 2: 87-92.
26. Roman GC, Tatemichi TK, Erkinjuntti T. et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993: 43: 250-60.
27. Wallin A., Blennow K. The clinical diagnosis of vascular dementia. Dementia 1994: 5: 181-4.
28. Byrne EJ. Diffuse Lewy body disease: disease, spectrum disorder or variety of Alzheimer disease (editorial). Int J Geriatr Psychiatry 1992: 7: 229-34.
29. Hachinski VC, Potter P., Merskey H. Leuko-araiosis. Arch Neurol 1987: 44: 21-3.
30. Risberg J. Development of high-resolution two-dimensional measurement of regional cerebral blood flow. In: Wade J. et al, eds. Impact of functional imaging in neurology and psychiatry. Current Problems in Neurology. vol 5. London: Libbey, 1987: 35-43.
31. George MS, Ring HA, Costa DC, Ell PJ, Kouris K., Jarritt PH. Neuroactivation and neuroimaging with SPECT. Berlin: Springer Verlag, 1991.
32. Rosén I., Gustafson L., Risberg J. Multichannel EEG frequency analysis and somatosensory-evoked potentials in patients with different types of organic dementia. Dementia 1993: 4: 43-9.
33. Blennow K., Wallin A., Häger O. Low frequency of post lumbar puncture headache in demented patients. Acta Neurol Scand 1993: 88: 221-3.
34. Rapoport S. Blood-brain barrier in physiology and medicine. New York: Raven Press, 1976: 129-52.
35. Poirier J., Baccichet A., Dea D., Gauthier S. Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience 1993: 55: 81-90.
36. Corder EH, Saunders AM, Strittmatter WJ et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993: 261: 921-3.
37. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993: 11: 575-80.
38. Frisoni GB, Bianchetti A., Govoni S., Trabucchi M., Calabresi L., Franceschini G. Association of apolipoprotein E4 with vascular dementia (letter). JAMA 1994: 271: 1317.
39. Pickering-Brown SM, Mann DM, Bourke JP et al. Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other beta-amyloid-forming diseases (letter). Lancet 1994: 343: 1155.